glp-1 face Demystifying “GLP1 Face” | Impressions + Body In honor of it being

In a survey, employers told the Business Group on Health that they arent yet seeing evidence of long-term health benefits from taking GLP-1s for weight loss, leaving them unsure how to manage costs while continuing to cover them.

Recent developments underscore the relevance of GLP-1R agonists in addressing the complex interplay of cardiovascular-kidney-metabolic (CKM) syndrome, microvascular dysfunction, and metabolic-associated steatohepatitis (MASH)

Think of your gut like a garden

GLP-1 receptor agonists got their start in an unlikely place: the mouth of a lizard

Understanding why provider guidance matters helps patients access these medications responsibly through appropriate channels

95% CI, -0.02 to 0.03